About Biologos
Biologos is a Healthcare company based in Chicago (United States) founded in 1976, and was acquired by Ampersand Capital in March 2024. Custom biologics are manufactured for research applications. The company has 26 employees. Biologos offers products and services including Buffers, Cell Culture Media, Enzymes, Reagents, and Salt Solutions. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Reagents and Kits and Cell Culture. Its competitors include GenScript, RoosterBio and OriGene; 3 of its 3 listed competitors have raised funding.
Company details
Founded in 1976 and based in Chicago, United States, Biologos operates in the biologics manufacturing sector. Standard and custom cell culture media, buffers, reagents, and sera are produced for research purposes. Quick-turn formulation, manufacturing, and distribution services are provided to support scientific applications across various research needs.
- Headquarters Chicago, United States
- Employees 26
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website biologos.com
- Social LinkedIn X Facebook Instagram
- Acquired by Ampersand Capital (Mar 2024)
- InvestorsEvolve Capital
& 2 more
- Employee Count26
- Acquired byAmpersand Capital
(Mar 2024)
Products & Services of Biologos
Biologos offers a comprehensive portfolio of products and services, including Buffers, Cell Culture Media, Enzymes, Reagents, and Salt Solutions.
Chemical buffers for biochemical and molecular applications
Nutrient media for cell growth in biopharma processes
Enzymes for diagnostic and tissue processing tasks
Custom reagents for various scientific applications
Solutions for cell and gene therapy procedures
Funding Insights of Biologos
- Total Rounds 1
- Investors Count 2
All 1 funding rounds of Biologos with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2015 | Private Equity Round | – | – |
3 investors in total: 3 institutional.
Investors in Biologos
Biologos has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Evolve Capital, Praesidian Capital and Ampersand Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| evolvecapital.com | ||||
Praesidian Capital is focused on private equity investments in lower middle market businesses. | 2002 | praesidian.com | Oklahoma City, United States | |
Ampersand Capital Partners is focused on investments in healthcare and life sciences. | ampersandcapital.com | Boston, United States |
Investor details for Biologos
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Biologos
9 people are tracked at Biologos (4 in leadership, 5 in team); the tracked headcount is 26.
| Name | Role | Group |
|---|---|---|
Jeff Holman | Chief Commercial Officer - CCO (acquired By Ampersand Capital Partners, 2024) | Leadership |
David Tate | Vice President Of Sales | Leadership |
Anthony Bazarko | President & Chief Executive Officer | Leadership |
Brendan Lucey | Head Of Strategy And Marketing | Leadership |
Tony Butler | Sales Executive, Midwest | Team |
Holly Huchel, RN | Sales Executive - Central Region | Team |
Lauren Nevel | Client Success Manager | Team |
Heather Justice, RN | Sales Manager | Team |
Karen Dakis | Commercial Operations Manager | Team |
Complete people profiles for Biologos
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Biologos
3 dated milestones of Biologos across 48 years, from founding to its latest funding, stage changes and deals.
- Founded Biologos is founded.
- Funding First funding round.
- Exit Acquired by Ampersand Capital.
Competitors of Biologos
Biologos has 3 listed competitors in our database, 3 of them funded. They include GenScript, RoosterBio and OriGene.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| genscript.com | 2002 | Piscataway, United States | $15M | 5,260 | Reagents and instruments are provided for life sciences research. | |
| roosterbio.com | 2012 | Frederick, United States | $38.41M | 69 | Developer of human mesenchymal stem cells and extracellular vesicles | |
| origene.com | 1996 | Rockville, United States | $69.55M | 141 | Proteins, antibodies, and molecular tools are manufactured for research applications. |
Detailed competitors of Biologos
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Biologos
The website of Biologos (biologos.com) receives about 3.2K visits a month.
- Monthly visits3.2K
▲ 20.9% vs previous month
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Biologos (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Biologos
Complete news archive for Biologos
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Biologos
Biologos was founded in 1976 and raised its 1st funding round 39 years after it was founded.
Biologos is headquartered in Chicago, United States. It is registered at Chicago, Illinois, United States.
Biologos has 26 employees.
Founded in 1976 and based in Chicago, United States, Biologos operates in the biologics manufacturing sector. Standard and custom cell culture media, buffers, reagents, and sera are produced for research purposes. Quick-turn formulation, manufacturing, and distribution services are provided to support scientific applications across various research needs.
Biologos's top competitors include RoosterBio, GenScript and OriGene.
Biologos offers Buffers, Cell Culture Media, Enzymes, Reagents, and Salt Solutions.
Biologos has 3 investors. Key investors include Evolve Capital, Praesidian Capital, and Ampersand Capital Partners.
Yes. Biologos was acquired by Ampersand Capital in March 2024.